Cardiology overview congenital heart disease: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Cardiology overview}} | {{Cardiology overview}} | ||
{{CMG}} | {{CMG}} | ||
==Atrial Septal Defect== | |||
===Treatment=== | |||
* An atrial septal occluder device can be used. There can be migration or erosion of the device so follow-up is warranted. | |||
==Coarctaion== | ==Coarctaion== | ||
Revision as of 19:57, 31 October 2011
|
Cardiology Overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Atrial Septal Defect
Treatment
- An atrial septal occluder device can be used. There can be migration or erosion of the device so follow-up is warranted.
Coarctaion
- May be associated with bicuspid aortic stenosis
- Imaging follow-up is recommended to look for aneurysm formation.
Mitochondrial Cardiomyopathy
- Mitochondrial cardiomyopathy is associated with an increase in the pCO2 due to a reduction in ventilation.
Patent Foramen Ovale (PFO)
Treatment
- In the PFO patient who has had their first cryptogenic stroke, the treatment of choice as aspirin.
- The benefit of PFO closure is not well established
- The benefit of Coumadin in the patient with PFO is not well established, and this therapy should be reserved for those patients with atrial fibrillation or venous thromboembolism.